Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy
O. Minenkova, D. Santapaola, F. M. Milazzo, A. M. Anastasi, G. Battistuzzi, C. Chiapparino, A. Rosi, G. Gritti, G. Borleri, A. Rambaldi, C. Dental, C. Viollet, B. Pagano, L. Salvini, E. Marra, , R. De Santis
This study identifies human antibody fragments that neutralize SARS-CoV-2 variants and show efficacy in animal models, suggesting potential for early COVID-19 therapy.
bioRxiv · Jun 4, 2021Bioengineering